According to a new market
report published by Lucintel, the future of the global interventional
cardiology and peripheral vascular device market looks promising with
opportunities in hospitals and ambulatory surgical centers. The global interventional
cardiology and peripheral vascular device market is expected to reach an
estimated $26.3 billion by 2023, and it is forecast to grow at a CAGR of 5.5%
from 2018 to 2023. The major drivers for the growth of this market include the growing
elderly population, a rise in the prevalence of chronic diseases, advancements
in medical technology and research, improvement
of healthcare infrastructure in developing countries, and change in lifestyles.
In this market, angioplasty
balloons, angioplasty stents, angioplasty catheters, EAVR stent grafts, IVC
filters, embolic protection devices, guidewires, arteriotomy closure devices, intravascular
ultrasound systems, and synthetic surgical grafts
are the segments by device type. On the basis of comprehensive research,
Lucintel forecasts that the EVAR stent graft segment will show above average
growth during the forecast period.
By end
use, the global interventional cardiology and peripheral vascular device market
is segmented into hospitals and ambulatory surgical centers. The hospital
segment is expected to remain the largest segment in the forecast period as hospitals
have a much higher budget than ambulatory surgical centers.
North America
is expected to remain the largest market during the forecast period mainly due
to its well-developed healthcare infrastructure and continued technological advancements
across the healthcare industry.
APAC is expected to witness the highest growth over the forecast period due
to improving healthcare infrastructure in developing economies like China and
India.
Emerging
trends which have a direct impact on the dynamics of the market include rising
adoption of TAVR procedures, increasing use of bioresorbable stents, and a rise
in adoption of drug eluting balloons. Medtronic Plc, Boston Scientific, Abbott
Laboratories, Terumo, and C R Bard are among the major suppliers of interventional
cardiology and peripheral vascular devices.
Lucintel, a
leading global strategic consulting and market research firm, has analyzed
growth opportunities in the global interventional cardiology and peripheral
vascular device market by type, device, end use, and region, and has compiled a
comprehensive research report entitled
“Growth
Opportunities in the Global Interventional Cardiology and Peripheral Vascular Device
Market 2018-2023: Trends, Forecast, and Opportunity Analysis.” The Lucintel report serves as a catalyst
for growth strategy by providing comprehensive data and analysis on trends, key
drivers, and directions. The study includes a forecast for the global interventional
cardiology and peripheral vascular device market by type, device, end use, and region, as follows:
By Type [Value
($ Million) from 2012 to 2023]:
· Peripheral
Vascular Device
By Device Type [Value ($ Million) from 2012 to 2023]:
- Angioplasty Balloons
- Angioplasty Stents
- Angioplasty Catheters
- EVAR stent graft
- IVC filter
- Embolic Protection Devices
- Guidewires
- Arteriotomy Closure Devices
- Intravascular Ultrasound System (IVUS)
- Synthetic Surgical Graft
By End Use
[Value ($ Million) for 2017 and 2023]:
·
Hospitals
·
Ambulatory Surgical Centers
By Region [Value
($ Million) from 2012 to 2023]:
· North America
− United States
− Canada
· Europe
− Germany
− France
− United Kingdom
− Italy
− Spain
· APAC
− Japan
− China
− India
· ROW
− Brazil
This 196-page research report will enable you to make confident business decisions in this
globally competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or helpdesk@lucintel.com. Lucintel offerings include
medical market analysis, medical market research, commercial due diligence report,
business strategy consulting and market research reports online.
About
Lucintel
Lucintel,
the premier global management consulting and market research firm, creates
winning strategies for growth. It offers market assessments, competitive
analysis, opportunity analysis, growth consulting, M&A, and due diligence
services to executives and key decision-makers in a variety of industries. For
further information, visit www.lucintel.com.
This report addresses the following key
questions:
Q. 1.
What are some of the most promising, high-growth opportunities for the global interventional
cardiology and peripheral vascular device market by type (interventional cardiology
device and peripheral vascular device), device (angioplasty
balloons, angioplasty stents, angioplasty catheters, EVAR stent grafts, IVC
filters, embolic protection devices, guidewires, arteriotomy closure devices, intravascular
ultrasound systems (IVUS), and synthetic surgical grafts), end use (hospitals
and ambulatory surgical centers) and region (North America, Europe, Asia
Pacific, and the Rest of the World)?
Q. 2. Which product segment will grow at a faster
pace and why?
Q. 3. Which
region will grow at a faster pace and why?
Q.4. What are the key factors affecting
market dynamics? What are the drivers, challenges, and business risks in this market?
Q.5. What
are the business risks and competitive threats in this market?
Q.6. What
are the emerging trends in this market and the reasons behind them?
Q.7. What
are some of the changing demands of customers in the market?
Q.8. What
are the new developments in the market and which companies are leading these developments?
Q.9. Who
are the major players in this market? What strategic initiatives are being
taken by key companies for business growth?
Q.10. What are some of the competing products in this
market and how big of a threat do they pose for loss of market share by product
substitution?
Q. 11. What M&A activity has occurred in
the last 5 years?
No comments:
Post a Comment